About this trial
The overall objective of this study is to determine the effects of ingesting protein that slowly releases amino acids into the blood vs. a control product on how our muscles regulate the synthesis of new proteins, termed muscle protein synthesis (MPS), in healthy volunteers.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Crossover
Treatments tested in this trial
Control Protein then Extended Release Nutritional Protein
Other interventionParticipants will consume a beverage with standard nutritional protein. Washout. Then participants will consume a beverage with extended release nutritional protein.
Extended Release Protein then Control Nutritional Protein
Other interventionParticipants will consume a beverage with extended release nutritional protein. Washout. Then, participants will consume a beverage with control nutritional protein.
Treatment groups
Trial outcomes
Primary outcomes
FSR
Secondary outcomes
FSR
FSR
Total Amino Acid 0-5 h incremental area-under-the-curve (iAUC)
Essential Amino Acid 0-5 h incremental area-under-the-curve (iAUC)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
VitaKey Inc.
Lead sponsor
United States Department of Defense (DOD)
Collaborator
Biofortis Clinical Research, Inc.
Collaborator
This trial is not recruiting at the moment. You can still explore other options: